GlassScriptPhysician profile
Steve Brian Behrens
NPI 1932305992
$158,436.99
in general payments reported to CMS, 2019-2025
33 companies · $42K in 2025
The $42K reported for 2025 was more than what 94% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $22K · 2021: $34K · 2022: $9,842 · 2023: $25K · 2024: $16K · 2025: $42K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $43K · Royalty Or License: $14K · Travel and Lodging: $9,439 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $8,000 · Food and Beverage: $7,860.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $42,827.50 |
| Royalty Or License | $13,909.84 |
| Travel and Lodging | $9,438.85 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $8,000.00 |
| Food and Beverage | $7,859.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $38,700.23 | 2019-2025 | Medline Industries, INC., Medline, Medline Unite |
| Synthes USA Products LLC | $34,295.91 | 2020-2025 | |
| Medical Device Business Services, INC. | $18,514.15 | 2019-2025 | Va-Lcp, Na |
| Medartis INC. | $12,301.48 | 2020-2025 | Aptus |
| Novastep INC. | $10,204.52 | 2022-2025 | Nexis |
| Spinesmith Holdings, LLC | $8,500.00 | 2021-2023 | |
| Depuy Synthes Sales INC. | $6,596.66 | 2019-2025 | Na, Motoband, Hammerlock |
| Gotham Surgical Solutions & Devices, INC. | $4,522.64 | 2020-2022 | |
| Depuy Synthes Products, INC. | $4,170.70 | 2019-2021 | |
| Medshape, INC. | $3,626.72 | 2019-2025 | Dynanail |
| Gramercy Extremity Orthopedics LLC | $2,940.89 | 2023-2024 | |
| Stryker Corporation | $2,656.19 | 2019-2024 | Infinity Adaptis, T2 Alpha, Ortholoc 3di |
| Arteriocyte Medical Systems, INC. | $2,094.74 | 2021-2025 | Magellan |
| Extremity Medical | $1,842.90 | 2023-2024 | Io Fix |
| Trilliant Surgical LLC. | $1,689.82 | 2022-2025 | Arsenal Ankle 10 Hole 1/3 Tubular Plate, Tiger Large Cannulated Instrument Module, Minimally Invasive Bunion Plate, Left |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Suvon Surgical LLC | $1,357.61 | 2022-2025 | |
| Wright Medical Technology, INC. | $874.61 | 2019-2020 | |
| Polynovo North America LLC | $700.91 | 2024-2025 | Novosorb Btm |
| Orthofix Medical, INC. | $557.16 | 2024-2025 | Physio-Stim |
| Royal Biologics, INC. | $450.29 | 2021-2022 | |
| Restor3d, INC. | $353.04 | 2021-2025 | |
| Encore Medical, LP | $192.12 | 2022 | |
| Acera Surgical, INC. | $168.37 | 2024 | Restrata Wound Matrix |
| Globus Medical, INC. | $166.78 | 2022-2025 | Vyrsa V1 |
| Integra Lifesciences Corporation | $156.28 | 2020 | |
| Heron Therapeutics, INC. | $155.16 | 2023-2024 | Zynrelef |
| Arthrex, INC. | $149.65 | 2024 | Arthrex |
| Acumed LLC | $103.21 | 2019 | |
| Treace Medical Concepts, INC. | $91.72 | 2024 | |
| Tenex Health INC. | $90.45 | 2019 | |
| Solventum Corporation | $87.74 | 2024-2025 | Prevena |
| Amgen INC. | $76.63 | 2019-2021 | |
| Bioventus LLC | $47.71 | 2021-2023 | Durolane |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steve Behrens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.